Impact of eplerenone on major cardiovascular outcomes in patients with systolic heart failure according to baseline heart rate
Sign Up to like & getrecommendations! Published in 2018 at "Clinical Research in Cardiology"
DOI: 10.1007/s00392-018-1410-4
Abstract: BackgroundIncreased resting heart rate is a risk factor for cardiovascular mortality and morbidity. Mineralocorticoid receptor antagonists (MRAs) have been shown to improve cardiac sympathetic nerve activity, reduce heart rate and attenuate left ventricular remodelling. Whether… read more here.
Keywords: heart rate; heart; eplerenone; heart failure ... See more keywords
Serum sodium and eplerenone use in patients with a myocardial infarction and left ventricular dysfunction or heart failure: insights from the EPHESUS trial
Sign Up to like & getrecommendations! Published in 2021 at "Clinical Research in Cardiology"
DOI: 10.1007/s00392-021-01853-8
Abstract: Sodium changes are common in myocardial infarction (MI) complicated with left ventricular systolic dysfunction (LVSD) and/or heart failure (HF). Sodium handling is fine-tuned in the distal nephron, were eplerenone exhibits some of its pleotropic effects.… read more here.
Keywords: serum sodium; myocardial infarction; sodium; eplerenone ... See more keywords
Reply to: ‘Current perspectives on the use of eplerenone for chronic central serous chorioretinopathy’
Sign Up to like & getrecommendations! Published in 2021 at "Eye"
DOI: 10.1038/s41433-020-01327-7
Abstract: We thank Drs Xia and Hua for their interest in our work [1]. The authors cite two retrospective studies with smaller numbers of patients than our prospective randomised trial and no control groups to suggest… read more here.
Keywords: chronic central; trial; central serous; serous chorioretinopathy ... See more keywords
Mineralocorticoid receptor (MR) antagonist eplerenone and MR modulator balcinrenone prevent renal extracellular matrix remodeling and inflammation via the MR/proteoglycan/TLR4 pathway.
Sign Up to like & getrecommendations! Published in 2024 at "Clinical science"
DOI: 10.1042/cs20240302
Abstract: Excessive activation of the mineralocorticoid receptor (MR) is implicated in cardiovascular and renal disease. Decreasing MR activation with MR antagonists (MRA) is effective to slow chronic kidney disease (CKD) progression and its cardiovascular comorbidities in… read more here.
Keywords: modulator balcinrenone; eplerenone; activation; mineralocorticoid receptor ... See more keywords
Development of eplerenone nano sono-crystals using factorial design: enhanced solubility and dissolution rate via anti solvent crystallization technique
Sign Up to like & getrecommendations! Published in 2022 at "Drug Development and Industrial Pharmacy"
DOI: 10.1080/03639045.2022.2160985
Abstract: Abstract Objective The purpose of this work was to improve EP solubility by using a sono-crystalization approach to reduce particle size and hence, increase the dissolution rate. Significance Eplerenone (EP) is an antagonist of the… read more here.
Keywords: solubility dissolution; rate; eplerenone; dissolution rate ... See more keywords
Effect of the Nonsteroidal Mineralocorticoid Receptor Blocker, Esaxerenone, on Nocturnal Hypertension: A Post Hoc Analysis of the ESAX-HTN Study
Sign Up to like & getrecommendations! Published in 2020 at "American Journal of Hypertension"
DOI: 10.1093/ajh/hpaa155
Abstract: Abstract BACKGROUND Nocturnal hypertension is an important phenotype of abnormal diurnal blood pressure (BP) variability and a known risk marker for target organ damage and cardiovascular events. This study aimed to assess the differential BP-lowering… read more here.
Keywords: nocturnal hypertension; post hoc; study; eplerenone ... See more keywords
A3067 Eplerenone inhibits the cell pyroptosis in contralateral kidney of UUO rats
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Hypertension"
DOI: 10.1097/01.hjh.0000548095.91094.dd
Abstract: Objectives: To investigate the inhibitory effect of eplerenone, an aldosterone receptor blocker, on cell pyroptosis in contralateral kidney of UUO rats, and to elucidate the role of aldosterone in the process of unilateral renal injury-induced… read more here.
Keywords: uuo rats; contralateral kidney; eplerenone; kidney uuo ... See more keywords
EPLERENONE VS IRBESARTAN AS FIRST LINE THERAPY IN OBESE HYPERTENSIVE PATIENTS: PRELIMINARY RESULTS OF HEBRO TRIAL IN AMBULATORY BLOOD PRESSURE MEASUREMENTS
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Hypertension"
DOI: 10.1097/01.hjh.0001019440.55864.d5
Abstract: Objective: Obesity is significantly associated with hypertension and cardiovascular outcomes. Little is known about the impact of aldosterone blockade using eplerenone on hypertensive obese patients as first line therapy. The aim of this study is… read more here.
Keywords: irbesartan arm; eplerenone; mmhg; ambulatory ... See more keywords
The selective mineralocorticoid receptor antagonist eplerenone prevents decompensation of the liver in cirrhosis
Sign Up to like & getrecommendations! Published in 2018 at "British Journal of Pharmacology"
DOI: 10.1111/bph.14341
Abstract: The mineralocorticoid receptor (MR) contributes to fibrosis in various tissues, and MR antagonists, like eplerenone, are used to prevent fibrosis. The role of MR antagonists in hepatic fibrosis and cirrhosis is unknown. Here, we investigated… read more here.
Keywords: receptor antagonist; cirrhosis; mineralocorticoid receptor; eplerenone ... See more keywords
Eplerenone for the treatment of chronic central serous chorioretinopathy: 3-year clinical experience
Sign Up to like & getrecommendations! Published in 2019 at "British Journal of Ophthalmology"
DOI: 10.1136/bjophthalmol-2019-314047
Abstract: Background/aims The efficacy of mineralocorticoid receptor antagonist eplerenone to treat chronic central serous chorioretinopathy (CSCR) has been established. However, previous studies have been limited by small cohort size and short follow-up duration. This study aims… read more here.
Keywords: chronic central; year; central serous; serous chorioretinopathy ... See more keywords
Abstract 4132062: Early changes in albuminuria and their interaction with eplerenone treatment in patients hospitalized for acute heart failure: findings from the EARLIER trial
Sign Up to like & getrecommendations! Published in 2024 at "Circulation"
DOI: 10.1161/circ.150.suppl_1.4132062
Abstract: Background: Patients hospitalized for acute heart failure (AHF) have high degrees of congestion, which may be associated with albuminuria. Mineralocorticoid receptor antagonists (MRAs) have natriuretic effects, possibly diminishing the degree of albuminuria. However, early changes… read more here.
Keywords: patients hospitalized; eplerenone; admission; hospitalized acute ... See more keywords